rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
2004-8-25
|
pubmed:abstractText |
Parenteral iron replacement and maintenance are frequently required in hemodialysis patients. However, serious adverse events have been reported after single doses of some intravenous iron products. This multicenter phase IV clinical trial examined the safety of iron sucrose for the treatment of iron deficiency and for the maintenance of iron sufficiency in hemodialysis patients.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0085-2538
|
pubmed:author |
pubmed-author:AronoffGeorge RGR,
pubmed-author:BennettWilliam MWM,
pubmed-author:BlumenthalSamuelS,
pubmed-author:CharytanChaimC,
pubmed-author:PennellJ PhillipJP,
pubmed-author:ReedJohnJ,
pubmed-author:RothsteinMarcosM,
pubmed-author:StromJamesJ,
pubmed-author:United States Iron Sucrose (Venofer) Clinical Trials Group,
pubmed-author:Van WyckDavidD,
pubmed-author:WolfeAnthonyA,
pubmed-author:YeeJerryJ
|
pubmed:issnType |
Print
|
pubmed:volume |
66
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1193-8
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15327417-Adult,
pubmed-meshheading:15327417-Aged,
pubmed-meshheading:15327417-Aged, 80 and over,
pubmed-meshheading:15327417-Anemia,
pubmed-meshheading:15327417-Drug Hypersensitivity,
pubmed-meshheading:15327417-Female,
pubmed-meshheading:15327417-Ferric Compounds,
pubmed-meshheading:15327417-Humans,
pubmed-meshheading:15327417-Kidney Failure, Chronic,
pubmed-meshheading:15327417-Male,
pubmed-meshheading:15327417-Middle Aged,
pubmed-meshheading:15327417-Renal Dialysis,
pubmed-meshheading:15327417-Sepsis
|
pubmed:year |
2004
|
pubmed:articleTitle |
Iron sucrose in hemodialysis patients: safety of replacement and maintenance regimens.
|
pubmed:affiliation |
University of Louisville School of Medicine, Louisville, Kentucky, USA.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Clinical Trial, Phase IV
|